Medicare Enrolled
Dr. David Konstandt, M.D.
Optician · Mooresville, NC
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Consulting-driven
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Konstandt from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Konstandt?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Konstandt
Dr. David Konstandt is an optician specialist in Mooresville, NC, with 20 years of NPI registration. Based on federal Medicare data, Dr. Konstandt performed 9,877 Medicare services across 3,094 unique beneficiaries.
Between the years covered by Open Payments, Dr. Konstandt received a total of $5,031 from 32 pharmaceutical and/or device companies across 103 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in optician. The majority of payments are for consulting, which typically reflects recognized clinical expertise sought by manufacturers. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Konstandt is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years in practice
▲ Top 5% volume in NC
$5,031 industry payments
Medicare Practice Summary
Medicare Utilization ↗9,877
Medicare services
Top 5% in NC for optician
3,094
Unique beneficiaries
$34
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~494 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Botox injection, per unit An injection of onabotulinumtoxinA, a medication used to temporarily relax muscles or reduce gland activity. The dose is measured in units, with this code representing a single unit administered. |
3,200 | $5 | $12 |
| BCG treatment for bladder cancer | 2,100 | $2 | $7 |
| Automated urinalysis An automated laboratory test performed on a urine sample to analyze its chemical and physical properties. The procedure uses machinery to detect various substances and cells within the urine. |
1,035 | $2 | $6 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
751 | $90 | $271 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
446 | $58 | $170 |
| Bladder ultrasound after voiding An ultrasound scan performed after urination to measure the amount of urine remaining in the bladder. |
411 | $7 | $46 |
| Ceftriaxone antibiotic injection This code represents the administration of ceftriaxone sodium, an antibiotic medication. The charge is calculated for every 250 mg of the drug administered. |
308 | $0 | $2 |
| Leuprolide acetate (for depot suspension), 7.5 mg | 195 | $133 | $650 |
| Complete ultrasound of retroperitoneum An ultrasound examination of the structures located behind the abdominal cavity. |
192 | $80 | $315 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
169 | $115 | $360 |
| Cystourethroscopy A diagnostic exam of the bladder and urethra using an endoscope to visually inspect the urinary tract. |
158 | $171 | $800 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
106 | $10 | $42 |
| Bladder irrigation and/or instillation This procedure involves flushing the bladder with fluid to clear it or introducing medication directly into the bladder. |
78 | $54 | $214 |
| Transrectal ultrasound of the pelvis An ultrasound imaging procedure where a probe is inserted into the rectum to visualize pelvic structures. |
76 | $103 | $350 |
| Electronic assessment of bladder emptying A test that uses electronic monitoring to evaluate how well the bladder empties urine. |
75 | $8 | $209 |
| Unclassified drug A medication that does not fit into standard HCPCS or CPT classification categories. |
73 | $520 | $727 |
| Hormone pellet insertion under the skin A small hormone pellet is placed just beneath the skin to release medication slowly over time. |
72 | $68 | $244 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
60 | $131 | $358 |
| Ultrasound guidance for needle placement Use of ultrasound imaging to guide the precise placement of a needle during a medical procedure. |
56 | $45 | $485 |
| Prostate gland biopsy A procedure to remove small samples of tissue from the prostate gland for laboratory examination. |
47 | $161 | $600 |
| Subcutaneous or intramuscular chemotherapy injection This procedure involves administering anti-cancer hormonal medication through an injection into the tissue under the skin or into a muscle. |
36 | $23 | $70 |
| Cystoscopy with chemical ablation of bladder A procedure where a camera is used to examine the bladder and a chemical agent is applied to destroy abnormal tissue. |
28 | $286 | $2,100 |
| New patient office visit, complex (60-74 min) | 26 | $132 | $419 |
| Office visit for established patient An office visit for an existing patient that may not require the healthcare professional to be present. |
26 | $16 | $51 |
| Imaging of urinary tract with contrast An imaging test of the urinary tract performed after a contrast agent is injected to enhance visibility of the structures. |
24 | $19 | $300 |
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
19 | $8 | $8 |
| Simple insertion of temporary bladder tube A procedure to place a temporary tube into the bladder. This allows for the drainage of urine from the bladder. |
18 | $42 | $188 |
| Shock wave crushing of kidney stones A procedure that uses shock waves to break kidney stones into smaller pieces so they can pass more easily from the body. |
14 | $429 | $2,134 |
| Endoscopic removal of foreign body, stone, or stent from urethra or bladder A procedure to remove a foreign object, stone, or stent from the urethra or bladder using an endoscope. The endoscope is a thin tube with a camera inserted into the urinary tract to locate and extract the item. |
14 | $217 | $626 |
| Ureteral stone crushing with stent insertion An endoscope is used to break up a stone in the ureter, followed by the placement of a stent to keep the ureter open. |
14 | $305 | $1,221 |
| Office visit, established patient (10-19 min) An office visit for an existing patient lasting 10 to 19 minutes. The visit involves medical evaluation and management of the patient's condition. |
14 | $40 | $114 |
| Abdominal device insertion with pressure and urine flow study A procedure involving the placement of a device into the abdomen, accompanied by a study to measure pressure and urine flow rate. |
13 | $115 | $400 |
| Injection of biodegradable material next to prostate A procedure involving the injection of a biodegradable substance into the tissue surrounding the prostate gland. |
12 | $2,177 | $9,500 |
| Initial hospital admission, moderate complexity Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter. |
11 | $100 | $321 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
0.6% high complexity
45.2% medium
54.2% routine
Industry Payment Transparency
Open Payments through 2024 ↗$5,031
Total received (2018-2024)
Avg $719/year across 7 years
Top 23% in NC for optician
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
32
Companies
103
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$2,445 (48.6%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$2,416 (48.0%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$170 (3.4%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$148
2023
$375
2022
$1,576
2021
$35
2020
$601
2019
$1,236
2018
$1,059
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Medtronic, Inc.
$129
Boston Scientific Corporation
$19
Top 3 companies account for 100.0% of 2024 payments
All-time payments by company (2018-2024) ›
Janssen Scientific Affairs, LLC
$1,515
Astellas Pharma US Inc
$899
Dendreon Pharmaceuticals LLC
$615
C. R. Bard, Inc. & Subsidiaries
$400
PROCEPT BioRobotics Corporation
$170
Medtronic, Inc.
$151
PFIZER INC.
$145
NeoTract Inc.
$141
Photocure Inc
$128
Bayer HealthCare Pharmaceuticals Inc.
$120
Amgen Inc.
$116
Boston Scientific Corporation
$114
Cardinal Health 108, LLC
$85
Blue Earth Diagnostics Limited
$50
Avadel Specialty Pharmaceuticals, LLC
$47
COLOPLAST CORP
$35
TOLMAR Pharmaceuticals, Inc.
$33
Allergan Inc.
$27
Ferring Pharmaceuticals Inc.
$24
Laborie Medical Technologies Corp.
$24
Rochester Medical Corporation
$22
Agiliti Surgical, Inc.
$20
Endo Pharmaceuticals Inc.
$19
Medtronic USA, Inc.
$17
Tolmar, Inc.
$17
Antares Pharma, Inc.
$16
Olympus America Inc.
$16
Axonics, Inc.
$15
Zyla Life Sciences
$14
Zyla Life Sciences, Inc.
$13
DENTSPLY IH Inc.
$12
Egalet US Inc
$11
Top 3 companies account for 60.2% of all-time payments
Associated products mentioned in payments ›
AQUABEAM ROBOTIC SYSTEM · Axumin · BOTOX · Bulkamid · Cysview · ELIGARD · ERLEADA · FIRMAGON · INTERSTIM · LITHOVUE · LoFric · MYRBETRIQ · Nexavar · Noctiva · OTREXUP · Olympus Laser Devices · PROVENGE · Prolia · REZUM · SPRIX · TOVIAZ · Titan · UroLift · VIAGRA · XGEVA · XIAFLEX · XTANDI · Xofigo
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
The majority of payments (49%) are consulting fees, which typically reflect recognized clinical expertise sought by manufacturers.
Geographic Context
Opticians within 10 mi
89
Per 100K population
46.4
County median income
$78,678
Nearest hospital
DUKE HEALTH LAKE NORMAN HOSPITAL
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Konstandt is a clinical cardiology specialist, with above-average Medicare volume (top 5% in NC), with consulting-driven industry engagement, with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Konstandt experienced with botox injection, per unit?
Based on Medicare claims data, Dr. Konstandt performed 3,200 botox injection, per unit services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Konstandt receive payments from pharmaceutical companies?
Yes. Dr. Konstandt received a total of $5,031 from 32 companies across 103 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Konstandt's costs compare to other opticians in Mooresville?
Dr. Konstandt's average Medicare payment per service is $34. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Konstandt) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Opticians in Mooresville
Browse opticians in Mooresville ranked by procedure volume and transparency data.
Highest volume
Top Opticians in NC
Opticians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Opticians in NC
Which NC opticians receive the most from drug and device companies.
By company
Janssen Scientific Affairs, LLC Payments to Doctors
See all physicians who received payments from Janssen Scientific Affairs, LLC.
By company
Astellas Pharma US Inc Payments to Doctors
See all physicians who received payments from Astellas Pharma US Inc.
By company
Dendreon Pharmaceuticals LLC Payments to Doctors
See all physicians who received payments from Dendreon Pharmaceuticals LLC.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology